Who owns Galectin Therapeutics?
- Ticker: GALT
- CUSIP Number: 363225202
Tip: Access positions for across all investors
Analyze quarterly positions in Galectin Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Galectin Therapeutics stock
Who bought or sold Galectin Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.0M | $4.7M | 2% | Mar 2024 |
|
| Advisor Group Holdings | 1.3M | $3.0M | 1% | Mar 2024 |
|
| BlackRock | 713k | $1.7M | -2% | Mar 2024 |
|
| Geode Capital Management | 567k | $1.4M | 11% | Mar 2024 |
|
| Geneos Wealth Management | 409k | $977k | -1% | Mar 2024 |
|
| Susquehanna International | 403k | $962k | 774% | Mar 2024 |
|
| Sontag Advisory | 398k | $952k | 117% | Mar 2024 |
|
| Atria Wealth Solutions | 215k | $513k | -14% | Mar 2024 |
|
| Morgan Stanley | 185k | $441k | 0% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 121k | $290k | -4% | Mar 2024 |
|
| Commonwealth Equity Services | 116k | $277k | 10% | Mar 2024 |
|
| Cutter & CO Brokerage | 116k | $276k | -2% | Mar 2024 |
|
| Northern Trust | 101k | $242k | -1% | Mar 2024 |
|
| Qube Research & Technologies | 69k | $165k | 1806% | Mar 2024 |
|
| LPL Financial | 55k | $132k | 6% | Mar 2024 |
|
| Horizon Kinetics Asset Management | 54k | $89k | -4% | Dec 2023 |
|
| Squarepoint Ops | 48k | $115k | 100% | Mar 2024 |
|
| D.A. Davidson & Co. | 48k | $114k | 12% | Mar 2024 |
|
| Stratos Wealth Partners | 41k | $97k | 0% | Mar 2024 |
|
| William Blair $ Company | 38k | $91k | 0% | Mar 2024 |
|
| Jane Street | 37k | $88k | 9% | Mar 2024 |
|
| Solutions 4 Wealth | 36k | $86k | 0% | Mar 2024 |
|
| Traynor Capital Management | 35k | $83k | 0% | Mar 2024 |
|
| Retirement Guys Formula | 34k | $81k | 57% | Mar 2024 |
|
| Citadel Advisors | 32k | $77k | 119% | Mar 2024 |
|
| Mariner Wealth Advisors | 28k | $68k | 161% | Mar 2024 |
|
| Millennium Management | 25k | $60k | -10% | Mar 2024 |
|
| Creative Planning | 24k | $58k | 0% | Mar 2024 |
|
| Vivaldi Capital Management | 24k | $73k | 25% | Mar 2024 |
|
| Beacon Capital Management | 24k | $57k | 0% | Mar 2024 |
|
| Summit Trail Advisors | 20k | $48k | 0% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 19k | $45k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 17k | $42k | 0% | Mar 2024 |
|
| Wedbush Morgan Securities | 16k | $26k | 0% | Dec 2023 |
|
| Bank of America Corporation | 15k | $35k | 162% | Mar 2024 |
|
| Buckingham Asset Management | 13k | $32k | 0% | Mar 2024 |
|
| Dynamic Advisors Solutions | 12k | $30k | 0% | Mar 2024 |
|
| Inspire Advisors | 11k | $27k | 0% | Mar 2024 |
|
| Y-Intercept | 11k | $27k | 100% | Mar 2024 |
|
| Wolverine Trading | 11k | $26k | 100% | Mar 2024 |
|
| Stock Yards Trust Company | 11k | $25k | 0% | Mar 2024 |
|
| Integrated Wealth Concepts | 10k | $24k | 0% | Mar 2024 |
|
| Simplex Trading | 7.9k | $18k | 13% | Mar 2024 |
|
| Wells Fargo & Company | 7.3k | $17k | -4% | Mar 2024 |
|
| Ronald Blue Trust | 7.0k | $17k | 0% | Mar 2024 |
|
| Tower Research Capital | 5.6k | $13k | -58% | Mar 2024 |
|
| Barrett & Company | 3.8k | $9.2k | 0% | Mar 2024 |
|
| Meeder Asset Management | 3.8k | $9.1k | 0% | Mar 2024 |
|
| Hartland & Co | 3.0k | $5.0k | 0% | Dec 2023 |
|
| Sound Income Strategies | 3.0k | $7.1k | 0% | Mar 2024 |
|
| IFP Advisors | 2.0k | $3.3k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.9k | $4.5k | 3% | Mar 2024 |
|
| Benjamin F. Edwards & Company | 1.8k | $4.0k | 0% | Mar 2024 |
|
| Bradley & Co. Private Wealth Management | 1.0k | $2.4k | 0% | Mar 2024 |
|
| Group One Trading | 542.00 | $1.3k | 100% | Mar 2024 |
|
| Global Retirement Partners | 250.00 | $598.000000 | 0% | Mar 2024 |
|
| Salem Investment Counselors | 167.00 | $399.998400 | 0% | Mar 2024 |
|
Who sold out of Galectin Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| 683 Capital Management | Dec 2023 | 111k | $184k |
| Independent Advisor Alliance | Dec 2023 | 36k | $60k |
| AE Wealth Management | Dec 2023 | 27k | $46k |
| Bank of New York Mellon | Dec 2023 | 23k | $38k |
| Citigroup | Dec 2023 | 11k | $18k |
| Gradient Investments | Dec 2023 | 3.8k | $6.3k |
| Royal Bank of Canada | Dec 2023 | 1.1k | $2.0k |
| UBS Group | Dec 2023 | 622.00 | $1.0k |